Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02125019 · ClinicalTrials.gov registry record
Longitudinal Evaluation of Taxane Induced Neuropathy in Early Stage Breast Cancer
A clinical trial, sponsored by Ohio State University Comprehensive Cancer Center.
- Completed
- Registry status
- 62
- Enrollment target
NCT02125019 is a clinical trial that has completed, run by Ohio State University Comprehensive Cancer Center. The registered enrollment target is 62 participants.
The verdict
NCT02125019 has completed, sponsored by Ohio State University Comprehensive Cancer Center.
- COMPLETED
- Registry status
- 62 participants
- Enrollment target
Study Summary
Longitudinal Evaluation of Taxane induced neuropathy in early stage breast cancer.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 62 participants |
| Start Date | 2013-12-04 |
| Est. Completion | 2018-05-14 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02125019
The ClinicalTrials.gov registry entry for NCT02125019 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 62 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ohio State University Comprehensive Cancer Center, which has 341 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02125019 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02125019 about?
NCT02125019 is a clinical study titled "Longitudinal Evaluation of Taxane Induced Neuropathy in Early Stage Breast Cancer". Longitudinal Evaluation of Taxane induced neuropathy in early stage breast cancer.
What is the current status of trial NCT02125019?
This trial is currently completed. The enrollment target is 62 participants. The study started on 2013-12-04. Estimated completion is 2018-05-14.
Who is sponsoring clinical trial NCT02125019?
This trial is sponsored by Ohio State University Comprehensive Cancer Center, which has 341 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.